Showing results (51-60 of 124) with videos related to

Sort By:
Pageof 13
Pathology International|January 18, 2018
Validation of the digital PCR system in tyrosine kinase inhibitor-resistant EGFR mutant non-small-cell lung cancerKatsuhiro Masago, Shiro Fujita, Akito Hata, et al.
Clinical Lung Cancer|December 16, 2011
Prognostic significance of preexisting interstitial lung disease in Japanese patients with small-cell lung cancerYosuke Togashi, Katsuhiro Masago, Tomohiro Handa, et al.
Thoracic Cancer|May 7, 2020
Targeted RNA sequencing with touch imprint cytology samples for non-small cell lung cancer patientsKatsutoshi Seto, Katsuhiro Masago, Shiro Fujita, et al.
Cancer Science|September 25, 2008
Clinical significance of pretreatment serum amphiregulin and transforming growth factor-alpha, and an epidermal growth factor receptor somatic mutation in patients with advanced non-squamous, non-small cell lung cancerKatsuhiro Masago, Shiro Fujita, Yukimasa Hatachi, et al.
Japanese Journal of Clinical Oncology|March 10, 2011
Two cases of cancer-associated retinopathy combined with small-cell lung cancerYuichi Sakamori, Young Hak Kim, Chiyuki Okuda, et al.
Oncology Letters|February 20, 2013
Pneumocystis jiroveci pneumonia and colonization in patients with advanced lung cancerYosuke Togashi, Katsuhiro Masago, Yutaka Ito, et al.
The Tohoku Journal of Experimental Medicine|September 4, 2010
Octreotide, a somatostatin analogue, in the treatment of chylothorax associated with idiopathic fibrosing mediastinitisYosuke Togashi, Young Hak Kim, Ryo Miyahara, et al.
Cancer Science|February 25, 2012
Increase in circulating endothelial progenitor cells predicts response in patients with advanced non-small-cell lung cancerYuichi Sakamori, Katsuhiro Masago, Katsuyuki Ohmori, et al.
Therapeutic Advances in Medical Oncology|March 5, 2020
Biomarker testing for personalized, first-line therapy in advanced nonsquamous non-small cell lung cancer patients in the real world setting in Japan: a retrospective, multicenter, observational study (the BRAVE study)Junichi Shimizu, Katsuhiro Masago, Haruhiro Saito, et al.
Clinical Lung Cancer|January 31, 2012
Expressions of insulin-like growth factor receptor-1 and insulin-like growth factor binding protein 3 in advanced non-small-cell lung cancerYoung Hak Kim, Shinji Sumiyoshi, Seiji Hashimoto, et al.
Pageof 13